Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEP uP Protocol in Critically Ill Surgical Patients
NCT02459275Phase 4Terminated
- Sponsor
- Kingston General Hospital
- Start
- Jul 2015
- Primary completion
- Sep 2017
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in critical illness, sponsored by Kingston General Hospital. Primary endpoints: Total Amount of Protein Received at 12 days and Total Amount of Energy Received at 12 days. Started Jul 2015; status: terminated.
02
Conditions
critical illness
Beyond the preview
Go deeper on NCT02459275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02459275.